Clinical Research Directory
Browse clinical research sites, groups, and studies.
Research OutSmarts Endometriosis II Study
Sponsor: Northwell Health
Summary
This product will be used as a diagnostic test to screen for the likelihood of endometriosis in menstruating adults with symptoms suggestive of endometriosis. The purpose of the test will be to guide clinical decisions regarding: 1) whether to undergo diagnostic laparoscopy to confirm the presence of endometriosis (currently, the gold standard for diagnosing endometriosis) and/or 2) how to guide the choice of hormonal or other therapies to treat symptoms of endometriosis.
Official title: ROSE II: Pilot Study to Analyze Menstrual Blood to Predict Endometriosis
Key Details
Gender
FEMALE
Age Range
18 Years - 40 Years
Study Type
OBSERVATIONAL
Enrollment
185
Start Date
2022-05-27
Completion Date
2025-06-01
Last Updated
2025-03-13
Healthy Volunteers
Yes
Conditions
Interventions
Analysis of menstrual blood to predict endometriosis
Menstrual blood from controls and symptomatic cases will be analyzed using single cell RNA-sequencing to develop a panel of biomarkers that can be developed into a screening test or diagnostic test for endometriosis.
Locations (1)
Feinstein Institutes/Northwell health
Manhasset, New York, United States